GSKGLAXF
13F holders, Q1 2025 (March 31)1holders −1
0new positions
1sold out
$18.87avg. 13F price*
At the end of Q1 2025, 1 institutions reported holding GSK PLC (GLAXF) in their 13F filings, down 1 from Q4 2024. 0 opened new positions and 1 sold out. The largest holder was Aristotle Capital Management, LLC ($58.2M).
- Company
- GSK PLC
- CUSIP
- G3910J179
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 1 | $101 |
All 13F filers, Q4 2024 → Q1 2025: 283,506 shares sold, net −283,506 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| Aristotle Capital Management, LLC | 0.12% | Reduce -8.4% | 3,083,338 | $58.2M |
"% of holder's portfolio" is GLAXF's weight in each manager's 13F, not the share of GSK PLC the manager owns.